You are about to leave this site and are being redirected to another site. Would you like to leave this site?

BAVENCIO in combination with INLYTA was studied vs sunitinib

See the study design

Safety profile

See the safety results

One treatment regimen, two different mechanisms of action

See the MOA

Support is available for
your eligible patients

Learn more

Support is available for eligible patient

Learn more